O
CUTR

OrbiMed’s Cutera, Inc. CUTR Stock Holding History

OrbiMed’s Portfolio CUTR Stock Details CUTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-603,100
Closed -$3.63M – 135
2023
Q3 		$3.63M Buy
603,100
+216,000
+56% +$2.74M 0.08% 105
2023
Q2 		$5.86M Buy
+387,100
New +$7.33M 0.11% 99

Other funds holding CUTR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

OrbiMed's CUTR Position: Q4 2023 in Review

OrbiMed sold out of Cutera, Inc. (CUTR) in Q4 2023, closing a stake of 603,100 shares — an estimated $3.63M sold.

OrbiMed first reported a position in CUTR in Q2 2023 and held it in 2 quarters. The position peaked at $5.86M in Q2 2023. 100 funds tracked by Wall St. Rank hold CUTR as of Q4 2023.

  • OrbiMed reported no remaining Cutera, Inc. position as of Q4 2023 after selling out during the quarter.
  • OrbiMed sold 603,100 Cutera, Inc. shares in Q4 2023, an estimated $3.63M.
  • OrbiMed first reported a position in Cutera, Inc. in Q2 2023 and held it in 2 quarters.
  • OrbiMed's Cutera, Inc. position peaked at $5.86M in Q2 2023.
  • 100 funds tracked by Wall St. Rank held Cutera, Inc. as of Q4 2023.

Based on OrbiMed's 13F filing for Q4 2023, filed 14 Feb 2024.